UT Southwestern biotech company lands another $80M about 18 months after last raise
October 22, 2021 at 23:59 PM EDT
ReCode Therapeutics is gearing up for human clinical trials of its primary ciliary dyskinesia (PCD) and cystic fibrosis therapies next year.
